High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$7.6M
$7,630,054
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
EWTX
S
Edgewise Therapeutics, Inc.
Donovan Joanne M.
• Officer • CMO
10b5-1 SellΔOwn -74.9%
2026-04-01
$926,095
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Officer • CMO
10b5-1 SellΔOwn -74.9%
|
2026-04-01 | $926,095 | S | Form 4 |
|
EWTX
S
Edgewise Therapeutics, Inc.
Donovan Joanne M.
• Officer • CMO
10b5-1 SellΔOwn -69.0%
2026-03-31
$685,308
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Officer • CMO
10b5-1 SellΔOwn -69.0%
|
2026-03-31 | $685,308 | S | Form 4 |
|
EWTX
S
Edgewise Therapeutics, Inc.
Donovan Joanne M.
• Officer • CMO
10b5-1 SellΔOwn -37.1%
2026-03-27
$506,735x2
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Officer • CMO
10b5-1 SellΔOwn -37.1%
|
2026-03-27 | $506,735x2 | S | Form 4 |
|
EWTX
S
Edgewise Therapeutics, Inc.
Edris Badreddin
• Director
10b5-1 Sell
2026-01-21
$3,399,466Largex5
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-01-21 | $3,399,466Largex5 | S | Form 4 |
|
EWTX
S
Edgewise Therapeutics, Inc.
Russell Alan J
• Officer • Chief Scientific Officer
Discretionary SellΔOwn -81.0%
2025-11-12
$2,112,450Large
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Discretionary SellΔOwn -81.0%
|
2025-11-12 | $2,112,450Large | S | Form 4 |